Biogut Technologies Inc, where we lead the charge in cutting-edge research at the nexus of the microbiome and health, unraveling the
mysteries of microbial metabolites and their profound impact on
human vitality.
We're driven by a relentless pursuit of scientific excellence, decoding the intricate microbiota and host physiology to pioneer transformative healthcare solutions, poised to reshape the landscape of healthcare for generations to come.
…want to know more?
IBD & Gut Fibrosis
Advancements in Gut Fibrosis
Explore our innovative solutions for inflammatory bowel disease (IBD) and fibrosis research and learn more about our transformative initiatives in IBD diagnostics and therapeutics.
Learn More
GELM-9
hTERT-Immortalised Human Myofibroblast Cell Line
Discover the hTERT immortalized myofibroblast cell line GELM-9, a powerful tool for studying fibrosis mechanisms and developing therapeutic interventions.
Learn More
Probiotic Therapeutics
Targeted Probiotic Therapies
Our advancements in probiotic therapeutics and innovative approach targets pathogens and cancer cells with precision, promising personalized treatment strategies and improved patient outcomes.
MMP Test
Personalized Microbiome Testing
Utilizing the Micrometabolomic Matrix Platform (MMP) Test, we offer actionable insights into patients' microbial composition, facilitating targeted probiotic interventions for enhanced outcomes.